You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
小智港股覆盤 | 12月29日
uSMART盈立智投 12-29 16:15

今日,港股三大指數集體下跌。截止收盤,恆生指數跌0.79%,報19741點。國企指數跌1.14%,報6695點。恆生科技指數大跌2.49%,報4107點。市場約606只個股上漲,1046只個股下跌。成交額突破907.53億港幣,和昨天同期相比下跌25.58%。南下資金淨流入40.01億港幣。

領跌板塊

盤面上,CRO板塊漲幅較前。康龍化成漲超7%;金斯瑞生物科技漲超5%;奧星生命科技、昭衍新藥等多股漲超4%;方達控股漲超3%

板塊行情

製藥板塊跟隨走強。遠大醫藥漲超14%;雅各臣科研製藥漲超9%;凱萊英漲超7%;歐康維視生物-B、聯邦製藥等多股漲超5%。遠大醫藥漲8.83%,抗新冠病毒感染3CL蛋白酶抑制劑GS221的臨牀試驗順利開展;凱萊英漲8%,機構指公司充分受益於Paxlovid新冠訂單,當前仍處於較低估位置。

板塊行情

互聯網板塊活躍。羚邦集團漲超4%;騰訊控股漲超2%

板塊行情

菸草板塊集體下挫。思摩爾國際跌超4%。思摩爾國際授出合共79.85萬股獎勵股份。

板塊行情

百貨零售板塊跌幅居前。歲寶百貨跌超14%;名創優品跌超6%;百盛集團跌超3%;利福中國跌超2%;恆基發展跌超1%

板塊行情

互聯網醫療板塊跌幅居前。阿裏健康、醫脈通等多股跌超4%;醫渡科技、中智全球等多股跌超3%;平安好醫生跌超2%

板塊行情

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account